Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma - Results of three consecutive phase II programs

Acta Oncologica

Volumn 39, Issue 4, 2000, Pages 501-508

  Tourani, Jean Marc ^a,e   Jaillon Abraham, Christine ^b   Coscas, Yvan ^c   Dabouis, Gerard ^d   Andrieu, Jean Marie ^b  

^a University of Poitiers   (France)

^b Hopital Laennec   (France)

^c City of Boulogne Hospital   (France)

^d CHU de Nantes   (France)

^e POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZAPRIDE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHYLPREDNISOLONE; VINDESINE;

ADULT; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MALE; NEPHROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL RATE; VOMITING;

EID: 0033799481     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750013429     Document Type: Article

References (23)

1. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung
2. Therapy of small cell lung cancer: A perspective on two decades of clinical research
3. Predictive value of regression rates following chemotherapy of small-cell lung carcinoma of the lung
4. Intensive chemotherapy of small cell bronchogenic carcinoma
5. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer
6. Maintenance chemotherapy in small-cell lung cancer: Long-term results of a randomized trial
7. Problems in radiographic estimation of response to chemotherapy and radiotherapy in smallt-cell lung cancer
8. Small cell lung cancer: State of the art therapy in 1996
9. Effect of thoracic radiotherapy on mortality in limited small-cell lung cancer. A meta-analysis of 13 randomized trials among 2140 patients
10. Limited stage small cell lung cancer: Patterns of intrathoracic recurrence and the implications of thoracic radiotherapy
11. Prophylactic cranial irradiation in limited small-cell lung cancer: Survival benefit in patients with favourable characteristics
12. Spinal cord metastasis in small-cell carcinoma of the lung
13. A randomized comparison of high-dose versus conventional dose cyclophosphamide, doxorubicin and vincristine for extensive-stage small-cell lung cancer: A phase III trial of the southeastern cancer study group
14. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
15. High-dose cyclophosphamide in the induction therapy of small-cell lung cancer: Minor improvements in rate of remission and survival
16. Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung
17. Chimiotherapie des cancers bronchiques a petites cellules: Importance pronostique d'une reponse complete (1280 patients)
18. Does chemotherapy-induced leukopenia predict a response in small cell lung cancer
19. Importance of timing for thoracic irradiation in the combined modality treatment of limited stage small-cell lung cancer
20. Long term results of platinum etoposide plus twice-daily thoracic radiotherapy for limited small-cell lung cancer: Results on 32 patients with 48 months minimum follow-up
21. Twice daily thoracic irradiation for limited small-cell lung cancer
22. Cisplatin and etoposide plus thoracic radiotherapy administered once or twice daily in limited stage small-cell lung cancer: Final report of intergroup trial 0096
23. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide